Myopia Progressing
10
1
6
1
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
10.0%
1 terminated out of 10 trials
50.0%
-36.6% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (10)
Myopia Control With a Innovative Spectacle Lens - A Cessation Study
Dynamic Pupil Variations and the Efficacy of Peripheral Defocus Spectacle Lenses in Slowing Myopia Progression
Effect of Branched-Chain Amino Acid Supplementation on Myopia Progression
Clinical Efficacy and Mechanism Exploration of MR-61 in Delaying the Progression of Myopia
3D Designed Defocus Lenses on Myopia Control in Children and Adolescents
Light Diffraction Glasses in Preventing and Controlling Myopia in Adolescents
Different Microlenses Array for Controlling Myopia Progression in Children and Adolescents
Comparison of MiSight 1-Day and Acuvue Oasys for Presbyopia in Myopic Children
Brain Visual Perception Training for Prevention and Control of Premyopia
Topical 0.01% Atropine for the Control of Fast Progressing Myopia